Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Abstract Text:

Hildrum,Arnstein Mykletun,Torstein Hole,Kristian Midthjell,Alv A Dahl, Hildrum,Arnstein Mykletun,Torstein Hole,Kristian Midthjell,Alv A Dahl,Bjørn Hildrum,Arnstein Mykletun,Torstein Hole,Kristian Midthjell,Alv A Dahl,

BACKGROUND: The 2005 International Diabetes Federation (IDF) definition of the metabolic syndrome was designed to be useful worldwide, but to date few prevalence studies have used that definition in European populations. We estimated the age- and sex-stratified prevalence of IDF-defined metabolic syndrome in a county of Norway and compared it with the prevalence estimated using the revised National Cholesterol Education Program-Adult Treatment Panel-III definition (2005 ATP III). METHODS: Cross-sectional analysis of 10,206 participants aged 20-89 years in the Nord-Trøndelag Health Study 1995-97 (HUNT 2). RESULTS: Prevalence of IDF-defined metabolic syndrome was 29.6% (95% CI: 28.8 to 30.5), compared to 25.9% (95% CI: 25.0 to 26.7) using the 2005 ATP III criteria. The prevalence of IDF-defined metabolic syndrome increased from 11.0% in the 20-29 years age group to 47.2% in the 80-89 years group in men, and from 9.2% to 64.4% for women in the corresponding age groups. Among men and women aged >or=60 years, the IDF criteria classified 56.7% and 75.0%, respectively, as having central obesity, and 89.3% and 90.9%, respectively, as being hypertensive. CONCLUSION: According to both definitions, the prevalence of the metabolic syndrome increased strongly with age. The IDF and the American Heart Association/National Heart, Lung, and Blood Institute guidelines for clinical management of metabolic syndrome would classify a high proportion of elderly Norwegians as in need of overall risk assessment for cardiovascular disease.

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Publishing Authors By Initials

B Hildrum,A Mykletun,T Hole,K Midthjell,AA Dahl,B Hildrum,A Mykletun,T Hole,K Midthjell,AA Dahl,B Hildrum,A Mykletun,T Hole,K Midthjell,AA Dahl,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: BMC public health

VOLUME: 7

Page Numbers: 220

Journal Abbreviation:

ISSN: 1471-2458

DAY: 29

MONTH: 08

YEAR: 2007

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100968562

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.

AFFILIATION: Department of Psychiatry, Namsos Hospital, Namsos, Norway. bjorn.hildrum@hnt.no

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BMC Public Health

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study Related Publications

• A controlled study of job strain in primary-treated cancer patients without metastases.
• A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production.
• A novel splice site mutation in EYA4 causes DFNA10 hearing loss.
• A prospective study of patterns of fatigue in multiple sclerosis.
• Adverse patient reactions during orthodontic treatment with fixed appliances.
• Affect regulation, brain development, and behavioral/emotional health in adolescence.
• Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
• Alterations in reward-related decision making in boys with recent and future depression.
• Assignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden.
• Attitudes and practices of pediatric oncology providers regarding fertility issues.
• CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model.
• Chop it, ChIP it, check it: the current status of chromatin immunoprecipitation.
• Concerns about infertility risks among pediatric oncology patients and their parents.
• HEMA reduces cell proliferation and induces apoptosis in vitro.
• In cyclosporine-induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?-Response.
• Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
• Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters.
• Molecular characterization of a novel X-linked syndrome involving developmental delay and deafness.
• Nanosized (mu12-Pt)Pd164-xPtx(CO)72(PPh3)20 (x approximately 7) containing Pt-centered four-shell 165-atom Pd-Pt core with unprecedented intershell bridging carbonyl ligands: comparative analysis of icosahedral shell-growth patterns with geometrically rel
• Neural systems of positive affect: relevance to understanding child and adolescent depression?
• Resilience among children and adolescents at risk for depression: Mediation and moderation across social and neurobiological contexts.
• Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
• Sleep and the developing brain.
• Sleeplessness and aggression in youth.
• The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.
• Vectors using the phospho-alpha-(1,1)-glucosidase-encoding gene treA of Bacillus subtilis as a reporter.
• Vincent's infection.
• Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress.
• [Adjuvant chemotherapy for colon cancer.]
• [In Process Citation]